Nanodrug delivery systems and cancer stem cells: From delivery carriers to treatment
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Rational design of nanotherapeutics based on the five features principle for potent elimination of cancer stem cells10.1021/acs.accounts.1c00635 ↗
2. Targeted drug delivery to cancer stem cells through nanotechnological approaches10.2174/1574888X15999201001204727 ↗
3. Cancer stem cells, cancer cell plasticity and radiation therapy10.1016/j.semcancer.2014.07.001 ↗
4. Nanomedicine-mediated cancer stem cell therapy10.1016/j.biomaterials.2015.09.037 ↗
5. Cancer stem cells: regulation programs, immunological properties and immunotherapy10.1016/j.semcancer.2018.05.001 ↗
6. Mitochondria-targeted tetrahedral DNA nanostructures for doxorubicin delivery and enhancement of apoptosis10.1039/C9TB02266J ↗
7. Nanotechnology for multimodal synergistic cancer therapy10.1021/acs.chemrev.7b00258 ↗
8. Mediating passive tumor accumulation through particle size, tumor type, and location10.1021/acs.nanolett.7b00021 ↗
9. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites10.1016/j.addr.2020.06.030 ↗
10. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems (vol 288, pg 62, 2018)10.1016/j.jconrel.2019.05.004 ↗
11. Combating cancer stem-like cell-derived resistance to anticancer protein by liposome-mediated acclimatization strategy10.1021/acs.nanolett.2c00004 ↗
12. Disruption of mitochondrial complexes in cancer stem cells through nano-based drug delivery: a promising mitochondrial medicine10.1007/s12013-013-9607-7 ↗
13. Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells10.1016/j.biomaterials.2011.09.055 ↗
14. Let-7 miRNA and CDK4 siRNA co-encapsulated in Herceptin-conjugated liposome for breast cancer stem cells
15. Cancer stem cells-emanated therapy resistance: implications for liposomal drug delivery systems10.1016/j.jconrel.2018.08.043 ↗
16. Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review10.3390/ijms19010195 ↗
17. Fab antibody fragment-functionalized liposomes for specific targeting of antigen-positive cells10.1016/j.nano.2017.09.003 ↗
18. Advances in cancer stem cell targeting: how to strike the evil at its root10.1016/j.addr.2017.07.013 ↗
19. Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells10.1002/glia.22708 ↗
20. Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells10.1080/2162402X.2018.1494108 ↗
21. Targeting cancer stem cells by oncolytic viruses and nano-mediated delivery10.2147/OTT.S279639 ↗
22. Enriched inhibition of cancer and stem-like cancer cells via STAT-3 modulating niclocelles10.1039/C5NR00403A ↗
23. Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo10.1016/j.jconrel.2021.01.022 ↗
24. Synthesis and characterization of pH-responsive PEG-Poly(beta-Amino Ester) block copolymer micelles as drug carriers to eliminate cancer stem cells10.3390/pharmaceutics12020111 ↗
25. Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells10.1016/j.nano.2015.07.009 ↗
26. Identification and targeting of stem cell-activated pathways in cancer therapy10.1155/2019/8549020 ↗
27. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression10.1038/s41565-017-0012-z ↗
28. Reduction of the therapeutic dose of silencing RNA by packaging it in extracellular vesicles via a pre-microRNA backbone10.1038/s41551-019-0502-4 ↗
29. M2 macrophage microvesicle-inspired nanovehicles improve accessibility to cancer cells and cancer stem cells in tumors10.1186/s12951-021-01143-5 ↗
30. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy10.1038/s41467-019-11718-4 ↗
31. Hierarchical nanocomposites of graphene oxide and PEGylated protoporphyrin as carriers to load doxorubicin hydrochloride for trimodal synergistic therapy10.1039/C8TB00733K ↗
32. Size effect of mesoporous organosilica nanoparticles on tumor penetration and accumulation10.1039/C9BM01164A ↗
33. One-pot growth of triangular SnS nanopyramids for photoacoustic imaging and photothermal ablation of tumors10.1039/C9NJ03045J ↗
34. Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor
35. Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy10.1016/j.biomaterials.2019.01.048 ↗
36. Multifunctional magnetic nanoplatform eliminates cancer stem cells via inhibiting the secretion of extracellular heat shock protein 9010.1002/adhm.201900160 ↗
37. Nanoparticle-me diate d specific elimination of soft cancer stem cells by targeting low cell stiffness10.1016/j.actbio.2021.08.053 ↗
38. Retinoic acid-loaded dendritic polyglycerol-conjugated gold nanostars for targeted photothermal therapy in breast cancer stem cells10.1021/acsnano.1c05452 ↗
39. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells10.1016/j.jconrel.2019.01.006 ↗
40. Targeted Drug/Gene/Photodynamic therapy via a stimuli-responsive dendritic-polymer-based nanococktail for treatment of EGFR-TKI-resistant non-small-cell lung cancer
41. A dendritic polymer-based nanosystem mediates drug penetration and irreversible endoplasmic reticulum stresses in tumor via neighboring effect10.1002/adma.202201200 ↗
42. PE38-based gene therapy of HER2-positive breast cancer stem cells via VHH-redirected polyamidoamine dendrimers10.1038/s41598-021-93972-5 ↗
43. Evaluation of cellular and transcriptional targeting of breast cancer stem cells via anti-HER2 nanobody conjugated PAMAM dendrimers10.1080/21691401.2018.1489269 ↗
44. Blocking sternness and metastatic properties of ovarian cancer cells by targeting p70(S6K) with dendrimer nanovector-based siRNA delivery10.1016/j.ymthe.2017.11.006 ↗
45. Development of functional dendrisomes based on a single molecule of polyesterbenzylether dendrimer and their application in cancer stem cell therapy10.1038/s41427-019-0134-x ↗
46. Biodegradable hydrogel with thermo-response and hemostatic effect for photothermal enhanced anti-infective therapy10.1016/j.nantod.2021.101165 ↗
47. In situ injection of dual-delivery PEG based MMP-2 sensitive hydrogels for enhanced tumor penetration and chemo-immune combination therapy10.1039/D1NR01155C ↗
48. Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth10.2147/IJN.S166104 ↗
49. Combined chemotherapy for triple negative breast cancer treatment by paclitaxel and niclosamide nanocrystals loaded thermosensitive hydrogel10.1016/j.ejps.2021.105992 ↗
50. Rapid reprogramming of tumour cells into cancer stem cells on double-network hydrogels10.1038/s41551-021-00692-2 ↗
51. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells10.1016/j.actbio.2019.05.040 ↗
52. Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathway10.1016/j.nano.2015.07.001 ↗
53. Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells10.18632/oncotarget.22322 ↗
54. A neutrophil-mediated carrier regulates tumor stemness by inhibiting autophagy to prevent postoperative triple-negative breast cancer recurrence and metastasis10.1016/j.actbio.2022.04.017 ↗
55. Cargo-free nanomedicine with pH sensitivity for codelivery of DOX conjugated prodrug with SN38 To synergistically eradicate breast cancer stem cells10.1021/acs.molpharmaceut.8b00367 ↗
56. A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase10.1016/j.biomaterials.2021.121180 ↗
57. Dual-responsive size-shrinking nanocluster with hierarchical disassembly capability for improved tumor penetration and therapeutic efficacy10.1021/acsami.8b21580 ↗
58. Carbon nanomaterials for targeted cancer therapy drugs: a critical review10.1002/tcr.201800038 ↗
59. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo10.1016/j.jconrel.2019.12.032 ↗
60. Redox-responsive polyethyleneimine/tetrahedron DNA/doxorubicin nanocomplexes for deep cell/tissue penetration to overcome multidrug resistance10.1016/j.jconrel.2020.11.050 ↗
61. MiR-486-5p Targets CD133+ lung cancer stem cells through the p85/AKT pathway10.3390/ph15030297 ↗
62. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism10.1016/j.cbi.2016.03.005 ↗
63. Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma10.18632/oncotarget.27305 ↗
64. The promotion of nanoparticle delivery to two populations of gastric cancer stem cells by CD133 and CD44 antibodies10.1016/j.biopha.2019.108857 ↗
65. The effect of metformin on the proliferation, apoptosis and CD133 mrna expression of colon cancer stem cells by upregulation of miR 342-3p10.2147/DDDT.S336490 ↗
66. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells10.1186/s12885-017-3731-5 ↗
67. Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells10.1007/s10495-019-01573-5 ↗
68. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas10.1093/carcin/bgz182 ↗
69. Propolis reduces the stemness of head and neck squamous cell carcinoma10.1016/j.archoralbio.2021.105087 ↗
70. Phenotyping and target expression profiling of CD34(+)/CD38(-) and CD34(+)/CD38(+)Stem- and progenitor cells in acute lymphoblastic leukemia10.1016/j.neo.2018.04.004 ↗
71. A 36-dimensional cytometry by time of flight (CyTOF) analysis of de novo acute myeloid leukemia (AML) patients eligible for intensive chemotherapy10.1182/blood-2018-99-116943 ↗
72. Targeting cancer stem cells by genetically engineered chimeric antigen receptor T cells10.3389/fgene.2020.00312 ↗
73. Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer10.7150/jca.28032 ↗
74. Prognosis assessment of CD44(+)/CD24(-) in breast cancer patients: a systematic review and meta-analysis
75. Function for KLF4 in Modulating the De-Differentiation of EpCAM(-)/CD133(-) nonStem Cells into EpCAM(+)/CD133(+) Liver Cancer Stem Cells in HCC Cell Line HuH7
76. The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers10.1016/j.clinre.2021.101664 ↗
77. MiR-29a-mediated CD133 expression contributes to cisplatin resistance in CD133(+) glioblastoma stem cells10.1007/s12031-018-1177-0 ↗
78. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells10.1002/stem.3337 ↗
79. CD133-and EpCAM-targeted liposome with Redox-responsive properties capable of synergistically eliminating liver cancer stem cells
80. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel10.1016/j.colsurfb.2016.03.075 ↗
81. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition10.1021/mp500290f ↗
82. Hyaluronidase and pH dual-responsive nanoparticles for targeted breast cancer stem cells10.3389/fonc.2021.760423 ↗
83. Cancer stem cells as a potential target to overcome multidrug resistance10.3389/fonc.2020.00764 ↗
84. Drug resistance and cancer stem cells10.1186/s12964-020-00627-5 ↗
85. Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles10.1038/cr.2016.53 ↗
86. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance10.1007/s00432-019-03080-1 ↗
87. Cancer stem cells, metabolism, and therapeutic significance10.1007/s13277-016-4945-x ↗
88. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes10.1016/j.biomaterials.2013.02.066 ↗
89. When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance10.1186/s40880-018-0317-9 ↗
90. Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells10.1016/j.stem.2016.11.004 ↗
91. Characteristics of the cancer stem cell niche and therapeutic strategies10.1186/s13287-022-02904-1 ↗
92. The scrambled story between hyaluronan and glioblastoma10.1016/j.jbc.2021.100549 ↗
93. The Importance of CD44 as a stem cell biomarker and therapeutic target in cancer
94. Transformable dual-inhibition system effectively suppresses renal cancer metastasis through blocking endothelial cells and cancer stem cells10.1002/smll.202070222 ↗
95. Targeting the biophysical properties of the myeloma initiating cell niches: a pharmaceutical synergism analysis using multi-scale agent-based modeling (vol 9, e85059, 2014)
96. Emerging agents that target signaling pathways in cancer stem cells10.1186/s13045-020-00901-6 ↗
97. Cancer stem cells,quo vadis? the notch signaling pathway in tumor initiation and progression10.3390/cells9081879 ↗
98. Unlocking the secrets of cancer stem cells with gamma-secretase inhibitors: a novel anticancer strategy10.3390/molecules26040972 ↗
99. Inhibiting notch activity in breast cancer stem cells by glucose functionalized nanoparticles carrying gamma-secretase inhibitors10.1038/mt.2016.42 ↗
100. Sulforaphane inhibits self-renewal of lung cancer stem cells through the modulation of sonic Hedgehog signaling pathway and polyhomeotic homolog 310.1186/s13568-021-01281-x ↗